ADAMTS-13 (VON WILLEBRAND FACTOR-CLEAVING PROTEASE) ACTIVITY IN THE EARLY AND LATE PHASES AFTER TRANSIENT ISCHAEMIC ATTACK OR ISCHAEMIC STROKE

被引：0
|
作者：
McCabe, D. J. H.
Starke, R.
Harrison, P.
Brown, M. M.
Sidhu, P. S.
Mackie, I. J.
Machin, S. J.
机构：
[1] Trinity Coll Dublin, AMNCH, Dept Neurol, Dublin, Ireland
[2] UCL, Stroke Res Grp, UCL Inst Neurol, London, England
[3] UCL, Dept Haematol, London, England
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2009年 / 80卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：103 / 104
页数：2
相关论文
共 50 条
  • [31] ADAMTS13, von Willebrand factor specific cleaving protease
    Veyradier, Agnes
    Coppo, Paul
    M S-MEDECINE SCIENCES, 2011, 27 (12): : 1097 - 1105
  • [32] Childhood lupus presenting as thrombotic microangiopathy with absent von Willebrand factor-cleaving protease (ADAMTS13) activity level
    Muscal, Eyal
    Edwards, Rachel M.
    Teruya, Jun
    Kearney, Debra L.
    Myones, Barry L.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (12): : 4268 - 4268
  • [33] Thrombotic thrombocytopenic purpura associated with von Willebrand factor-cleaving protease (ADAMTS13) deficiency in children
    Loirat, C
    Veyradier, A
    Girma, JP
    Ribba, AS
    Meyer, D
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2006, 32 (02): : 90 - 97
  • [34] Atypical hemolytic and uremic syndrome associated with von Willebrand factor-cleaving protease (ADAMTS 13) deficiency in children
    Chabchoub, R. Ben Abdallah
    Boukedi, A.
    BenSalah, M.
    Maalej, B.
    Gargour, L.
    Turk, F.
    Ben Halima, N.
    Wolf, M.
    Veyradier, A.
    Mahfoudh, A.
    ARCHIVES DE PEDIATRIE, 2013, 20 (08): : 853 - 857
  • [35] Changes in plasma von Willebrand factor-cleaving protease(ADAMTS13) levels in patients with unstable angina
    Fuchigami, Shunichiro
    Kaikita, Koichi
    Soejima, Kenji
    Miura, Mitsutoshi
    Matsukawa, Masakazu
    Honda, Tsuyoshi
    Tsujita, Kenichi
    Sugiyama, Seigo
    Ogawa, Hisao
    CIRCULATION, 2007, 116 (16) : 91 - 91
  • [36] Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura
    Zheng, XL
    Chung, D
    Takayama, TK
    Majerus, EM
    Sadler, JE
    Fujikawa, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (44) : 41059 - 41063
  • [37] ADAMTS13: von Willebrand factor cleaving protease .... growth factor?
    Keener, J. M.
    Hoyt, C.
    Rodgers, G. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 767 - 767
  • [38] Impact of Reduced Von Willebrand Factor-Cleaving Protease [ADAMTS13] In Pediatric Stroke: A Nested Case-Control Study
    Nowak-Gotil, Ulrike
    Lambers, Moritz
    Thedieck, Sabine
    Manner, Daniela
    Mesters, Rolf M.
    Junker, Ralf
    Stoll, Monika
    BLOOD, 2010, 116 (21) : 352 - 353
  • [39] Von Willebrand factor cleaving protease (ADAMTS-13) activity is stable in a set of plasma samples after prolonged storage at-80 °C
    Perutelli, P
    Amato, S
    Calevo, MG
    Molinari, AC
    THROMBOSIS RESEARCH, 2005, 116 (05) : 443 - 445
  • [40] von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in TIA or ischaemic stroke patients changing antiplatelet therapy
    Smith, D. R.
    Lim, S. T.
    Murphy, S. J. X.
    Hickey, F. B.
    Offiah, C.
    Murphy, S. M.
    Collins, D. R.
    Coughlan, T.
    O'Neill, D.
    Egan, B.
    O'Donnell, J. S.
    O'Sullivan, J. M.
    McCabe, D. J. H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 463
12345